Hypercholesterolemia is a risk factor for bioprosthetic valve calcification and explantation

Journal of Thoracic and Cardiovascular Surgery

Volumn 126, Issue 4, 2003, Pages 969-975

  Farivar, Robert Saeid ^b   Cohn, Lawrence H ^a   Miller, D Craig ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; EOSIN; HEMATOXYLIN;

ADULT; AGED; AORTA VALVE REPLACEMENT; ARTICLE; ATHEROSCLEROSIS; BIOPROSTHESIS; CALCIFICATION; CASE CONTROL STUDY; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATION ANALYSIS; DIABETES MELLITUS; EXPLANT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REPLACEMENT; MULTIPLE REGRESSION; PRIORITY JOURNAL; RADIOCARDIOGRAPHY; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0142182683     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5223(03)00708-6     Document Type: Article

References (23)

1. Cohn LH, Collins JJ Jr, Rizzo RJ, Adams DH, Couper GS, Aranki SF. Twenty-year follow-up of the Hancock modified orifice porcine aortic valve. Ann Thorac Surg. 1998;66(suppl):S30-4.
2. Jamieson W, Burr L, Munro A, Miyagishima R. Carpentier-Edwards standard porcine bioprosthesis: a 21-year experience. Ann Thorac Surg. 1998;66(suppl):S40-S43.
3. Schoen FJ. Cardiac valve prostheses: review of clinical status and contemporary biomaterials issues. J Biomed Mater Res. 1987;21:91-117.
4. Mohler ER 3rd. Are atherosclerotic processes involved in aortic-valve calcification? Lancet. 2000;356:524-5.
5. Demer LL. Cholesterol in vascular and valvular calcification. Circulation. 2001;104:1881-3.
6. Pohle K, Maffert R, Ropers D, et al. Progression of aortic valve calcification: association with coronary atherosclerosis and cardiovascular risk factors. Circulation. 2001;104:1927-32.
7. Callister TQ, Raggi P, Cooil B, Lippolis NJ, Russo DJ. Effect of HMG-CoA reductase inhibitors on coronary artery disease as assessed by electron-beam computed tomography. N Engl J Med. 1998;339:1972-8.
8. Bild D, Folsom A, Lowe L, et al. Prevalence and correlates of coronary calcification in black and white young adults: the coronary artery risk development in young adults (CARDIA) study. Arterioscler Thromb Vasc Biol. 2001;21:421-6.
9. Shavelle D, Takasu J, Budoff M, Mao S, Zhao X, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 2002;359:1125-6.
10. Pearlman A. Medical treatment of aortic stenosis: promising or wishful thinking. J Am Coll Cardiol. 2002;40:1731-4.
11. O'Brien MF. What is the progression of aortic valve stenosis (bicuspid, congenital, acquired, degenerative)? Can this progression be modified by statin therapy? Is "prophylactic" AVR for mild AS indicated during CABG? Presented as an abstract at the American College of Cardiology, Hawaii, February 2003. American College of Cardiology; 2003.
12. Palta S, Pai AM, Gill KS, Pai RG. New insights into the progression of aortic stenosis: implications for secondary prevention. Circulation. 2000;101:2497-502.
13. Jones EL, Weintraub WS, Craver JM, Guyton RM, Shen Y. Interaction of age and coronary disease after valve replacement: implication for valve selection. Ann Thorac Surg. 1994;58:378-85.
14. Kirklin JK, Smith D, Novick W, et al. Long-term function of cryopreserved aortic homografts: a ten-year study. J Thorac Cardiovasc Surg. 1993;106:154-66.
15. Cleveland D, Williams W, Razzouk A, et al. Failure of cryopreserved homograft valved conduits in the pulmonary circulation. Circulation. 1992;86(suppl):II150-3.
16. Miller D, Stinson E, Oyer P, et al. The durability of porcine xenograft valves and conduits in children. Circulation. 1982;66(suppl):I172-85.
17. Bellamy M, Pellika P, Klarish K, et al. Association of cholesterol levels, hydroxymethylglutaryl coenzyme-A reductase inhibitor treatment, and progression of aortic stenosis in the community. J Am Coll Cardiol. 2002;40:1723-30.
18. Novaro GM, Tiong IY, Pearce GL, Lauer MS, Sprecher DL, Griffin BP. Effect of hydroxymethylglutaryl coenzyme A reductase inhibitors on the progression of calcific aortic stenosis. Circulation. 2001;104:2205-9.
19. Aronow W, Ahn C, Kronzon I, Goldman M. Association of coronary risk factors and use of statins with progression of mild valvular aortic stenosis in older persons. Am J Cardiol. 2001;88:693-5.
20. Vyavahare NR, Jones PL, Hirsch D, Schoen FJ, Levy RJ. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies. J Heart Valve Dis. 2000;9:561-6.
21. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999;19:1218-22.
22. Chin H, Harrison E, Blankenhorn D, Moacanin J. Lipids in silicone rubber valve prostheses after human implantation. Circulation. 1971;43/44(suppl):I51-6.
23. Ferrans VJ, McManus B, Roberts WC. Cholesteryl ester crystals in a porcine aortic valvular bioprosthesis implanted for eight years. Chest. 1983;83:698-701.